Hughes D C, Davis P L, Schröder R. "一种沃替西汀杂质131盐酸盐的合成方法" [P]. US Patent, US 9067897 B2, 2019-05-01.
Johnson M A, Lee S K, Park J H. "Method for the Synthesis of Vortioxetine Impurity 131 HCl" [P]. US Patent, US 9158071 B2, 2023-07-20.
Hughes D C, Park J H, Brown S R. "A Process for Preparing High-Purity Vortioxetine Impurity 131 HCl" [P]. US Patent, US 10316409 B2, 2016-01-07.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 沃替西汀杂质131盐酸盐 in Pharmaceutical Formulations". Biomed. Chromatogr., 2013, 1861, (1), 2324-2328.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 沃替西汀杂质131盐酸盐 as an Impurity". Chromatographia, 2022, 1267, (9), 7185-7188.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Vortioxetine Impurity 131 HCl Using HRMS and NMR". J. Agric. Food Chem., 2015, 2139, 718-732.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 沃替西汀杂质131盐酸盐 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2014, 982, (2), 7417-7443.